Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) insider Micah Mitchell sold 90,231 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were sold at an average price of $0.86, for a total transaction of $77,598.66. Following the completion of the sale, the insider directly owned 109,478 shares of the company’s stock, valued at $94,151.08. The trade was a 45.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Myomo Trading Up 2.5%
NYSEAMERICAN:MYO traded up $0.02 during trading hours on Friday, hitting $0.91. The stock had a trading volume of 505,712 shares, compared to its average volume of 419,217. Myomo, Inc. has a one year low of $0.61 and a one year high of $3.69. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.93 and a current ratio of 2.73. The company has a market cap of $35.17 million, a price-to-earnings ratio of -2.53 and a beta of 1.39. The business’s 50 day moving average is $0.76 and its 200-day moving average is $0.85.
Analyst Upgrades and Downgrades
Separately, Craig Hallum reiterated a “buy” rating on shares of Myomo in a report on Tuesday, March 10th. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $7.67.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE boosted its holdings in shares of Myomo by 93.6% in the third quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock valued at $27,000 after buying an additional 14,705 shares during the period. Wells Fargo & Company MN boosted its holdings in shares of Myomo by 103.1% in the fourth quarter. Wells Fargo & Company MN now owns 38,707 shares of the company’s stock valued at $35,000 after buying an additional 19,646 shares during the period. Invesco Ltd. acquired a new position in shares of Myomo in the second quarter valued at approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Myomo in the second quarter valued at approximately $38,000. Finally, Jane Street Group LLC acquired a new position in shares of Myomo in the fourth quarter valued at approximately $64,000. Institutional investors and hedge funds own 44.99% of the company’s stock.
Myomo Company Profile
Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.
Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.
Featured Articles
- Five stocks we like better than Myomo
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.
